SweetBiotix Overview and Update

AI SummaryClose X

OptiBiotix Health plc has announced a significant breakthrough in its SweetBiotix® product manufacturing process, utilizing a new single enzyme that achieves approximately 90% yields, resulting in a purer, more concentrated, and better-tasting product with substantially lower production costs. This improved process works on both mogrosides and stevia glycosides, enabling the creation of multiple SweetBiotix products with a wide sweetness range, thereby increasing partnering and product opportunities. Notably, the new enzyme can convert sucrose into a healthy prebiotic fiber, transforming a commoditized ingredient into a higher-value product and potentially shifting sugar producers from competitors to partners. The company has received £550k in milestone payments from its US partner by the end of 2024, with further demonstrations of SweetBiotix products anticipated in the first half of 2026.

Disclaimer*

UK 100

Latest directors dealings